China Pharma Holdings (CPHI) Total Debt Growth (3y) (2013 - 2026)
China Pharma Holdings (CPHI) Total Debt Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 92.83% |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 | -11.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.08% |
| Dec 31, 2025 | -16.23% |
| Sep 30, 2025 | -24.78% |
| Jun 30, 2025 | -5.51% |
| Mar 31, 2025 | -18.44% |
| Dec 31, 2024 | -22.78% |
| Sep 30, 2024 | 15.56% |
| Jun 30, 2024 | -0.87% |
| Mar 31, 2024 | -6.50% |
| Dec 31, 2023 | -4.71% |
| Sep 30, 2023 | 34.06% |
| Jun 30, 2023 | -3.71% |
| Mar 31, 2023 | -10.88% |
| Dec 31, 2022 | -17.20% |
| Sep 30, 2022 | 2.71% |
| Jun 30, 2022 | -20.36% |
| Mar 31, 2022 | -10.45% |
| Dec 31, 2021 | -2.79% |
| Sep 30, 2021 | -37.50% |
| Jun 30, 2021 | -34.61% |